03:21 AM EDT, 08/11/2026 (MT Newswires) -- Moberg Pharma (MOB.ST) appointed Helena Jansson as chief business officer and deputy chief executive officer and Vaidrius Navikas as chief medical officer. Jansson most recently served as managing director at Palette Life Sciences, while Navikas was head of global medical affairs at H. Lundbeck (HLUN-A.CO, HLUN-B.CO), the Swedish pharmaceutical company said Tuesday.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.